PharmGKB:  The Pharmacogenetics and Pharmacogenomics Knowledge Base
Search PharmGKB:?
 

Important Variant Information for ADRB2

Submitted by: Gus Litonjua, Jaekyu Shin, Julie A. Johnson and Scott T. Weiss (PHAT and PEAR)
Reviewed by: Reviewed
Submitted date: March 22, 2006

There are Two Important Variants for ADRB2.

  1. ADRB2:16 Arg>Gly (rs1042713)
  2. ADRB2:27 Glu>Gln (rs1042714)


1. ADRB2:16 Arg>Gly (rs1042713)

Gene HGNC Name: ADRB2
Variant Summary: Among Caucasians, the estimated allele frequencies are: Arg16=0.393 and Gly16=0.607. The estimated allele frequency of Arg16 among Blacks is 0.492, while among Chinese it is 0.510.

Asthma and response to beta2-agonist therapy: Three recent meta-analyses have shown that the Arg16Gly polymorphism is not associated with asthma [PMID: 15867853, 15987731, and 15153795]. The Gly16 allele has been associated with nocturnal asthma and with severe asthma [PMID: 15987731]. Subjects who are homozygous Arg16 and who are on regular albuterol treatment were reported to have lower morning peak flows compared with those who were not on regular albuterol treatment [PMID: 15500895].

Agonist-mediated vascular response: The Arg16 allele is associated with enhanced isoproterenol- mediated vascular desensitization in healthy volunteers [PMID: 11586955]. Long-term terbutaline treatment desensitizes venous beta2-AR in a haplotype-dependent manner, with Arg16Gln27Thr164 showing greater desensitization than haplotype Gly16Gln27Thr164, which shows greater desensitization than Gly16Glu27Thr164 [PMID: 16153394].

Heart failure: The Arg16 allele is associated with higher peak oxygen consumption (peak VO2) compared to Gly16 in heart failure patients [PMID: 10785504]. However, Arg16Gly polymorphism was not associated with the improvement of left ventricular ejection fraction and decrease in heart rate to a beta blocker in stable congestive heart failure [PMID: 15861037]. In one study, the Arg16 allele was associated with lower risk of death or heart transplantation in idiopathic dilated heart failure patients [PMID: 15464701].

Acute coronary syndrome: Among the patients prescribed beta-blocker therapy after an acute coronary syndrome, patients homozygous for Arg16 had higher mortality rate (20%) vs. Gly16 carriers (10%) during 3 year follow-up period. In addition, those homozygous for both Arg16 and Gln27 were at higher risk for death in 3 years (3-year mortality rate 20%) compared to the other diplotypes (3-year mortality rate 6-11%) [PMID: 16189366].
Key PubMed IDs: 15867853, 15987731, 15153795, 11586955, 16153394, 10785504, 15861037, 15464701, 16189366
Genomic Variant & GenBank ID: 9,369,376 A>G on NT_029289
mRNA Variant & GenBank ID: 265 A>G on NM_000024
Protein Variant & GenBank ID: 16 Arg>Gly on NP_000015
dbSNP rs#: rs1042713
GoldenPath Position: chr5:148,186,633  (hg18)
Key Drugs/Substrates: Albuterol [PMID: 15500895],
isoproterenol [PMID: 11586955],
terbutaline [PMID: 16153394],
beta blockers [PMID: 16189366]
Key Phenotypes/Diseases: Asthma [PMID: 15867853, 15987731, 15153795];
bronchodilator response [PMID: 10340917, 10984540];
peak expiratory flow rate [PMID: 15500895];
agonist-mediated vascular response [PMID: 11586955];
heart failure  [PMID: 10785504, 15464701];
acute coronary syndrome [PMID: 16189366]
Phenotype Data Sets: Both Arg16Gly and Gln27Glu have been shown to correlate with the phenotype of bronchodilator responsiveness in asthma [Phenotype file "Bronchodilator response to beta agonist in asthmatics" (PA134686740);
PMID: 10984540] .


2. ADRB2:27 Glu>Gln(rs1042714)

Gene HGNC Name: ADRB2
Variant Summary: Among Caucasians, the estimated allele frequencies are Gln27=0.754 and Glu27=0.246. The Gln27 allele is more frequent among Blacks (0.813) and among Chinese (0.910). The Glu27 allele is thought to be resistant to down regulation of the receptor [PMID: 7915137, 7598936].

Agonist-mediated vascular response: In healthy subjects, homozygous Glu27 was associated with increased isoproterenol-mediated venodilatation compared to those homozygous for Gly27 [PMID: 11586955]. Long-term terbutaline treatment desensitized venous beta2-AR in a haplotype-dependent manner, with Arg16Gln27Thr164 showing greater desensitization than haplotype Gly16Gln27Thr164, which showed greater desensitization than Gly16Glu27Thr164 [PMID: 16153394].

Heart failure: Heart failure patients homozygous for Gln27 were less likely to have improved left ventricular ejection fraction after carvedilol treatment compared to Glu27 carriers [PMID: 12835612]. However, in another study of heart failure patients, Gln27Glu polymorphism was not associated with the improvement of left ventricular ejection fraction or decrease in heart rate to a beta blocker [PMID: 15861037]. In one study, the Gln27 allele was associated with a lower risk for death or heart transplantation in idiopathic dilated heart failure [PMID:15464701].

Acute coronary syndrome: Among patients prescribed beta-blocker therapy after an acute coronary syndrome, patients homozygous for Gln27 had higher mortality rate (16%) compared to those heterozygous and homozygous for Glu27 (11% and 6%, respectively). In addition, those homozygous for both Arg16 and Gln27 were at higher risk for death in 3 years (3-year mortality rate 20%) compared to the other diplotypes (3-year mortality rate 6-11%) [PMID: 16189366].
Key PubMed IDs: 7915137, 7598936, 15867853, 15987731, 15153795, 11586955, 16153394, 12835612, 15861037, 15464701, 16189366
Genomic Variant & GenBank ID: 9,369,409 G>C on NT_029289
mRNA Variant & GenBank ID: 298 G>C on NM_000024
Protein Variant & GenBank ID: 27 Glu>Gln on NP_000015
dbSNP rs#: rs1042714
GoldenPath Position: chr5:148,186,666  (hg18)
Key Drugs/Substrates: Albuterol [PMID: 15500895],
isoproterenol [PMID: 11586955],
terbutaline [PMID: 16153394],
beta blockers [PMID: 12835612, 16189366]
Key Phenotypes/Diseases: Asthma [PMID: 15867853, 15987731, 15153795];
bronchodilator response [PMID: 10984540];
agonist-mediated vascular response [PMID: 11586955];
heart failure [PMID: 15464701];
acute coronary syndrome [PMID: 16189366]
Phenotype Data Sets: Both Arg16Gly and Gln27Glu have been shown to correlate with the phenotype of bronchodilator responsiveness in asthma [Phenotype file "Bronchodilator response to beta agonist in asthmatics" (PA134686740) ; PMID: 10984540].
The PGRN is financially supported by grants from NIGMS, NHLBI, NHGRI, NIEHS, NCI, and NLM within the NIH, HHS. PharmGKB is managed at Stanford University. This work is supported by the NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM61374). ©2001-2008 PharmGKB.